Philadelphia Negative MPNs, MDS/MPNs and MDS in the Context of Recent WHO Changes and Inclusion of Molecular Signatures into Prognostic Tools: A Single Centre Experience
Introduction: The fifth edition of WHO classification of myeloid neoplasms has introduced major changes in the defining criteria and grouping of MDS, MDS/MPNs and MPNs. Recently published literature has also cited the importance of new risk-scoring systems by integrating genomic profiling with hemat...
Main Authors: | Neha Singh, Sujeet Kumar, Avinash Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
West Asia Organization for Cancer Prevention
2023-01-01
|
Series: | Asian Pacific Journal of Cancer Biology |
Subjects: | |
Online Access: | http://www.waocp.com/journal/index.php/apjcb/article/view/984 |
Similar Items
-
Myeloproliferative neoplasms (MPNs) – Part 1: An overview of the diagnosis and treatment of the “classical” MPNs
by: Sabrina Fowlkes, et al.
Published: (2018-10-01) -
Myeloproliferative neoplasms (MPNs) – Part 2: A nursing guide to managing the symptom burden of MPNs
by: Sabrina Fowlkes, et al.
Published: (2018-10-01) -
The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms
by: Giuseppe Lanzarone, et al.
Published: (2021-08-01) -
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
by: Vibe Skov
Published: (2020-08-01) -
Allogeneic Stem Cell Transplantation for MDS
by: Sara Villar, et al.
Published: (2021-08-01)